GoodRx appointed KPMG as its independent registered public accounting firm for the fiscal year ending December 31, 2026, and dismissed PwC. PwC’s audit reports for the years ended December 31, 2025 and 2024 contained no adverse opinion or disclaimer and were not qualified or modified. GoodRx reported no disagreements with PwC on accounting principles or practices, financial statement disclosure, or audit scope or procedure through March 14, 2026. The company also reported no reportable events involving PwC during that period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoodRx Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001809519-26-000059), on March 18, 2026, and is solely responsible for the information contained therein.
Comments